BUD APAC (01876.HK) +0.110 (+1.405%) Short selling $57.35M; Ratio 36.830% has announced its 2025 results, with the 4Q25 revenue/ volume/ average price/ EBITDA declining by 4.2%/ 0.7%/ 3.5%/ 24.7% YoY (all YoY changes are organic growth rates), according to a CICC report.As for BUD APAC's China operations, the company's revenue/ volume/ average price/ EBITDA decreased by 11.4%/ 3.9%/ 7.7%/ 42.3% YoY. The performance continued to adjust, in line with CICC's expectations.Related NewsCLSA Keeps Outperform Rating on BUD APAC (01876.HK), Lowers Earnings ForecastsConsidering that BUD APAC may moderately ramp up investment, CICC cut its 2026 EBITDA for the company by 7.1% to USD1.593 billion and estimated the 2027 EBITDA at USD1.637 billion.CICC kept BUD APAC's target price at HKD9.8 and its rating as Outperform.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-02-13 16:25.)